AstraZeneca gets marketing permission for leukaemia drug in India
The receipt of this permission paves way for the launch of the capsules in India AstraZeneca Pharma has received approval from…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Drugs Controller General (India)
NATCO receives DCG(I) approval for hepatitis C drug
The company plans to launch this combination drug immediately, under its brand name Hepcinat LP Natco Pharma has received…
India, UK health regulators sign MoU
The central understandings of the agreement include promotion of each other's regulatory frameworks, requirements and processes…
Maharashtra FDA chief Harshadeep Kamble to head top panel on online pharmacies
The sub-committee was formed by Drugs Controller General (India) to assess feasibility of online pharmacies, which was a result of…
DCG(I) to formulate guidelines for e-commerce marketplace to ensure safety of consumers
FICCI appointed as the nodal agency for consolidating the guidelines The role, responsibilities and liabilities of e-commerce…
‘We are estimating revenue of Rs 75 crores in 2016’
Indian clinical research organisations are witnessing a downshift and companies are learning from others
US FDA, DCG(I) explore more ways to work together
Willing to collaborate with Indian regulators, other stakeholders: US FDA
US FDA, DCG(I) explore more ways to work together
Willing to collaborate with Indian regulators, other stakeholders: US FDA
DoP declares 2015 as ‘Year of Active Pharmaceutical Ingredients’
BDMA in association with DoP, GoI will conduct a number of programmes in New Delhi on February 4